Sophisticated and simple
Overview: 10x Genomics Reports Preliminary 2025 Results 10x Genomics, a leader in single-cell and spatial biology, released preliminary, unaudited select results for the fourth quarter…

Cogent Biosciences Advances Precision Medicine with New Drug Application Submission Cogent Biosciences, a biotechnology company dedicated to developing precision therapies for genetically defined diseases, announced…

Overview of the Quarter Compugen released its third-quarter 2025 results, underscoring advances in its oncology program and the ongoing development of the COM701 program. The…

BlueWillow’s Intranasal Bird Flu Vaccine: A New Era for Mucosal Immunity BlueWillow Biologics, a leading clinical-stage biotech company, has announced positive findings from a peer-reviewed…
